Literature DB >> 12495807

Psychopathology influences treatment retention among drug-dependent women.

Deborah L Haller1, Donna R Miles, Kathryn S Dawson.   

Abstract

Three subgroups of drug dependent women (N = 78) were identified through cluster analysis on MCMI-II scores. Group 1 (26%) presented a relatively benign clinical picture. In contrast, Group 2 (37%) evidenced severe addiction, psychiatric (Axis I), and personality (Axis II) problems. Group 3 (37%) was characterized by fewer Axis I problems, prominent addiction and externalizing (Cluster B) personality deficits. Group membership was significantly associated with retention in a gender-specific day treatment program. Group 2 experienced rapid attrition, with only 36% completing treatment, compared to 57% for Group 1 and 76% for Group 3. Results indicate that drug-dependent women with externalizing psychopathology can be retained in treatment when environmental barriers are removed and an adequate "holding environment" is maintained. However, women with severe psychiatric problems, unstable mood, and interpersonal deficits are less likely to complete treatment. Early identification of women at risk for drop-out affords an opportunity to intervene to prevent its occurrence.

Entities:  

Mesh:

Year:  2002        PMID: 12495807     DOI: 10.1016/s0740-5472(02)00283-0

Source DB:  PubMed          Journal:  J Subst Abuse Treat        ISSN: 0740-5472


  9 in total

1.  Comparing Perceived Adequacy of Help Received Among Different Classes of Individuals with Severe Mental Disorders at Five-Year Follow-Up: A Longitudinal Cluster Analysis.

Authors:  Marie-Josée Fleury; Guy Grenier; Jean-Marie Bamvita
Journal:  Community Ment Health J       Date:  2017-11-13

2.  The impact of mood disorders on the delivery and neonatal outcomes of methadone-maintained pregnant patients.

Authors:  Michelle Tuten; Sarah H Heil; Kevin E O'Grady; Heather Fitzsimons; Margaret S Chisolm; Hendrée E Jones
Journal:  Am J Drug Alcohol Abuse       Date:  2009       Impact factor: 3.829

3.  Screening for Mood Disorder in Pregnant Substance-dependent Patients.

Authors:  Margaret S Chisolm; Michelle Tuten; Eric C Strain; Hendrée E Jones
Journal:  Addict Disord Their Treat       Date:  2009-06-01

4.  Treatment dropout in drug-addicted women: are eating disorders implicated?

Authors:  F Bonfà; S Cabrini; M Avanzi; O Bettinardi; R Spotti; E Uber
Journal:  Eat Weight Disord       Date:  2008-06       Impact factor: 4.652

5.  Millon Clinical Multiaxial Inventory-III subtypes of opioid dependence: validity and matching to behavioral therapies.

Authors:  Samuel A Ball; Charla Nich; Bruce J Rounsaville; Dorothy Eagan; Kathleen M Carroll
Journal:  J Consult Clin Psychol       Date:  2004-08

6.  Individual and program predictors of attrition from VA substance use treatment.

Authors:  Geoffrey M Curran; Tracy Stecker; Xiaotong Han; Brenda M Booth
Journal:  J Behav Health Serv Res       Date:  2008-01-11       Impact factor: 1.505

7.  The Impact of Acculturation, Motivation and the Therapeutic Alliance on Treatment Retention and Outcomes for Hispanic Drug Involved Probationers.

Authors:  Jo Brocato
Journal:  J Ethn Crim Justice       Date:  2013-01-01

8.  The comparative effectiveness of Integrated treatment for Substance abuse and Partner violence (I-StoP) and substance abuse treatment alone: a randomized controlled trial.

Authors:  Fleur L Kraanen; Ellen Vedel; Agnes Scholing; Paul M G Emmelkamp
Journal:  BMC Psychiatry       Date:  2013-07-16       Impact factor: 3.630

Review 9.  Psychiatric Co-Morbidities in Pregnant Women with Opioid Use Disorders: Prevalence, Impact, and Implications for Treatment.

Authors:  Camila L Arnaudo; Barbara Andraka-Christou; Kacy Allgood
Journal:  Curr Addict Rep       Date:  2017-03-09
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.